Biotest Pharmaceuticals Corporation Announces the Relocation of its Plasma Collection Facility in Gainesville, Florida

Friday, January 27, 2017 Corporate News
Email Print This Page Comment bookmark
Font : A-A+

BOCA RATON, Fla., Jan. 27, 2017 /PRNewswire/ -- Biotest Pharmaceuticals Corporation (BPC), a leader in the collection of

source plasma, is pleased to announce the relocation of its Gainesville plasma collection center to 2315 NW 13th Street, Gainesville, Florida. The 15,000 square foot state-of-the-art
facility officially opened its doors for business on Sunday, January 22, 2017.

"The relocation of this facility represents our continued commitment to enhance our donors experience and to secure quality supply of the raw materials needed to help the thousands of patients that rely on plasma based therapies" said Ileana Carlisle, BPC's Chief Executive Officer.

The plasma collected at Biotest Plasma Centers is used to manufacture critical care therapies that treat life threatening disorders in a variety of therapeutic areas.

The Company anticipates that this newly relocated facility will expand its current workforce to over 50 employees and currently has employment opportunities available for medical personnel and phlebotomists.

In addition to supporting the local economy through employment opportunities, the plasma center is actively recruiting local residents to donate plasma. Plasma donors not only contribute the source material for plasma derived therapies but also are compensated for their donations.

About Biotest Pharmaceuticals Corporation

Biotest Pharmaceuticals is a wholly-owned subsidiary of Biotest AG, a German global provider of plasma products. The Company owns and manages twenty two plasmapheresis centers across the United States researches, develops and manufactures biotherapeutic plasma protein products, with a specialization in immunology and hematology and is a leader in the collection of source plasma. Biotest Pharmaceuticals owns and manages plasmapheresis centers across the United States and operates a state-of-the-art manufacturing facility in Boca Raton, Florida. We are committed to serving the thousands of patients worldwide who rely on plasma-based therapies.

Biotest Pharmaceuticals' team of over 1000 employees is part of Biotest AG's global workforce of more than 2,300 associates worldwide. To learn more about Biotest Pharmaceuticals, our Plasma Centers, and the difference we make in the lives of patients and the healthcare community, please visit us at www.biotestpharma.com and www.biotestplasma.com.  

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/biotest-pharmaceuticals-corporation-announces-the-relocation-of-its-plasma-collection-facility-in-gainesville-florida-300397977.html

SOURCE Biotest Pharmaceuticals Corporation



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook